Form 4: West Pharmaceutical Services Executive Sells Shares
Insider Transaction (Form 4)
Annette F Favorite, Sr. VP & Chief HR Officer of West Pharmaceutical Services Inc, sold 7,524 shares of common stock on September 11, 2026.
Summary
- Option exercise/conversion: acquired 2,500 Common Stock at $89.64 ($224,100) on September 11, 2026; holds 24,318 after (Direct).
- Open-market sale: disposed of 2,500 Common Stock at $345.00 ($862,500) on September 11, 2026; holds 21,818 after (Direct).
- Option exercise/conversion: acquired 2,500 Common Stock at $89.64 ($224,100) on September 14, 2026; holds 24,318 after (Direct).
- Open-market sale: disposed of 2,500 Common Stock at $355.00 ($887,500) on September 14, 2026; holds 21,818 after (Direct).
- Option exercise/conversion: acquired 2,524 Common Stock at $89.64 ($226,251) on September 15, 2026; holds 24,342 after (Direct).
- Open-market sale: disposed of 2,524 Common Stock at $365.00 ($921,260) on September 15, 2026; holds 21,818 after (Direct).
- Option exercise/conversion: disposed of 2,500 Stock Option (Right to Buy) on September 11, 2026; holds 5,024 after (Direct).
- Option exercise/conversion: disposed of 2,500 Stock Option (Right to Buy) on September 14, 2026; holds 2,524 after (Direct).
- Option exercise/conversion: disposed of 2,524 Stock Option (Right to Buy) on September 15, 2026 (Direct).
Sentiment
Score: 4
Explanation: StockSavvy.ai views this as a mildly negative but low-conviction signal: an insider sold $2,671,260 of stock under a pre-arranged Rule 10b5-1 plan, which is typically routine.
Insider Transactions
Annette F Favorite — Officer (Sr. VP & Chief HR Officer)
Transaction made under a Rule 10b5-1 trading plan.
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-09-11 | Option exercise/conversion | Common Stock | 2,500 | $90 | $224.1K | 24,317.81 |
| 2026-09-11 | Open-market sale | Common Stock | 2,500 | $345 | $862.5K | 21,817.81 |
| 2026-09-14 | Option exercise/conversion | Common Stock | 2,500 | $90 | $224.1K | 24,317.81 |
| 2026-09-14 | Open-market sale | Common Stock | 2,500 | $355 | $887.5K | 21,817.81 |
| 2026-09-15 | Option exercise/conversion | Common Stock | 2,524 | $90 | $226.3K | 24,341.81 |
| 2026-09-15 | Open-market sale | Common Stock | 2,524 | $365 | $921.3K | 21,817.81 |
| 2026-09-11 | Option exercise/conversion | Stock Option (Right to Buy) | 2,500 | — | — | 5,024 |
| 2026-09-14 | Option exercise/conversion | Stock Option (Right to Buy) | 2,500 | — | — | 2,524 |
| 2026-09-15 | Option exercise/conversion | Stock Option (Right to Buy) | 2,524 | — | — | 0 |
Key Dates
| Date | Description |
|---|---|
| 2026-09-11 | Option exercise/conversion (2,500 shares) |
| 2026-09-11 | Open-market sale (2,500 shares) |
| 2026-09-14 | Option exercise/conversion (2,500 shares) |
| 2026-09-14 | Open-market sale (2,500 shares) |
| 2026-09-15 | Option exercise/conversion (2,524 shares) |
| 2026-09-15 | Open-market sale (2,524 shares) |
| 2026-09-11 | Option exercise/conversion (2,500 shares) |
| 2026-09-14 | Option exercise/conversion (2,500 shares) |
| 2026-09-15 | Option exercise/conversion (2,524 shares) |
Keywords
insider transaction, Form 4, WST, WEST PHARMACEUTICAL SERVICES INC, bearish, Annette F Favorite
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.